Oral vancomycin in the treatment of primary sclerosing cholangitis-associated pouchitis

作     者：Bo Shen 

作者机构：Center for Inflammatory Bowel DiseaseColumbia University Irving Medical CenterNew York Presbyterian HospitalNew YorkNYUSA 

出 版 物：《Gastroenterology Report》 (胃肠病学报道（英文）)

年 卷 期：2021年第9卷第3期

页      面：274-275,I0003页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：pouchitis primary sclerosing cholangitis vancomycin 

摘      要：Introduction Pouchitis is a common complication in those with restorative proctocolectomy with ileal pouch–anal anastomosis(IPAA).Some patients may develop chronic antibiotic-refractory pouchitis and its management can be *** sclerosing cholangitis(PSC)has consistently been reported to be a risk factor for chronic *** with PSC-associated pouchitis and enteritis may represent a unique phenotype[1]that usually does not respond to conventional antibiotics,such as metronidazole and ***-associated pouchitis has been treated with budesonide[2].